Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34


Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional Consequences.

Quinlan MA, Krout D, Katamish RM, Robson MJ, Nettesheim C, Gresch PJ, Mash DC, Henry LK, Blakely RD.

ACS Chem Neurosci. 2019 Jul 17;10(7):3249-3260. doi: 10.1021/acschemneuro.8b00689. Epub 2019 Feb 5.


Contribution of isopentenyl phosphate to plant terpenoid metabolism.

Henry LK, Thomas ST, Widhalm JR, Lynch JH, Davis TC, Kessler SA, Bohlmann J, Noel JP, Dudareva N.

Nat Plants. 2018 Sep;4(9):721-729. doi: 10.1038/s41477-018-0220-z. Epub 2018 Aug 20.


Identification of the benztropine analog [125I]GA II 34 binding site on the human dopamine transporter.

Tomlinson MJ, Krout D, Pramod AB, Lever JR, Newman AH, Henry LK, Vaughan RA.

Neurochem Int. 2019 Feb;123:34-45. doi: 10.1016/j.neuint.2018.08.008. Epub 2018 Aug 17.


The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission.

Sambo DO, Lin M, Owens A, Lebowitz JJ, Richardson B, Jagnarine DA, Shetty M, Rodriquez M, Alonge T, Ali M, Katz J, Yan L, Febo M, Henry LK, Bruijnzeel AW, Daws L, Khoshbouei H.

Nat Commun. 2017 Dec 20;8(1):2228. doi: 10.1038/s41467-017-02087-x.


Corrigendum to "The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux" [Biochem. Pharmacol. 120 (2016) 46-55].

Sealover NR, Felts B, Kuntz CP, Jarrard RE, Hockerman GH, Lamb PW, Barker EL, Henry LK.

Biochem Pharmacol. 2018 Jan;147:9. doi: 10.1016/j.bcp.2017.11.001. Epub 2017 Nov 28. No abstract available.


Inhibitor mechanisms in the S1 binding site of the dopamine transporter defined by multi-site molecular tethering of photoactive cocaine analogs.

Krout D, Pramod AB, Dahal RA, Tomlinson MJ, Sharma B, Foster JD, Zou MF, Boatang C, Newman AH, Lever JR, Vaughan RA, Henry LK.

Biochem Pharmacol. 2017 Oct 15;142:204-215. doi: 10.1016/j.bcp.2017.07.015. Epub 2017 Jul 19.


Blockade of the 5-HT transporter contributes to the behavioural, neuronal and molecular effects of cocaine.

Simmler LD, Anacker AMJ, Levin MH, Vaswani NM, Gresch PJ, Nackenoff AG, Anastasio NC, Stutz SJ, Cunningham KA, Wang J, Zhang B, Henry LK, Stewart A, Veenstra-VanderWeele J, Blakely RD.

Br J Pharmacol. 2017 Aug;174(16):2716-2738. doi: 10.1111/bph.13899. Epub 2017 Jul 11.


Inhibition of the Serotonin Transporter Is Altered by Metabolites of Selective Serotonin and Norepinephrine Reuptake Inhibitors and Represents a Caution to Acute or Chronic Treatment Paradigms.

Krout D, Rodriquez M, Brose SA, Golovko MY, Henry LK, Thompson BJ.

ACS Chem Neurosci. 2017 May 17;8(5):1011-1018. doi: 10.1021/acschemneuro.6b00343. Epub 2016 Dec 28.


The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux.

Sealover NR, Felts B, Kuntz CP, Jarrard RE, Hockerman GH, Lamb PW, Barker EL, Henry LK.

Biochem Pharmacol. 2016 Nov 15;120:46-55. doi: 10.1016/j.bcp.2016.09.006. Epub 2016 Sep 13. Erratum in: Biochem Pharmacol. 2017 Nov 28;147:9.


Membrane potential shapes regulation of dopamine transporter trafficking at the plasma membrane.

Richardson BD, Saha K, Krout D, Cabrera E, Felts B, Henry LK, Swant J, Zou MF, Newman AH, Khoshbouei H.

Nat Commun. 2016 Jan 25;7:10423. doi: 10.1038/ncomms10423.


Orthologs of the archaeal isopentenyl phosphate kinase regulate terpenoid production in plants.

Henry LK, Gutensohn M, Thomas ST, Noel JP, Dudareva N.

Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):10050-5. doi: 10.1073/pnas.1504798112. Epub 2015 Jul 27.


Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram.

Kumar V, Yarravarapu N, Lapinsky DJ, Perley D, Felts B, Tomlinson MJ, Vaughan RA, Henry LK, Lever JR, Newman AH.

J Med Chem. 2015 Jul 23;58(14):5609-19. doi: 10.1021/acs.jmedchem.5b00682. Epub 2015 Jul 8.


SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.

Bowton E, Saunders C, Reddy IA, Campbell NG, Hamilton PJ, Henry LK, Coon H, Sakrikar D, Veenstra-VanderWeele JM, Blakely RD, Sutcliffe J, Matthies HJ, Erreger K, Galli A.

Transl Psychiatry. 2014 Oct 14;4:e464. doi: 10.1038/tp.2014.90.


Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding site.

Dahal RA, Pramod AB, Sharma B, Krout D, Foster JD, Cha JH, Cao J, Newman AH, Lever JR, Vaughan RA, Henry LK.

J Biol Chem. 2014 Oct 24;289(43):29712-27. doi: 10.1074/jbc.M114.571521. Epub 2014 Aug 31.


The two Na+ sites in the human serotonin transporter play distinct roles in the ion coupling and electrogenicity of transport.

Felts B, Pramod AB, Sandtner W, Burbach N, Bulling S, Sitte HH, Henry LK.

J Biol Chem. 2014 Jan 17;289(3):1825-40. doi: 10.1074/jbc.M113.504654. Epub 2013 Nov 29.


Antagonist-induced conformational changes in dopamine transporter extracellular loop two involve residues in a potential salt bridge.

Gaffaney JD, Shetty M, Felts B, Pramod AB, Foster JD, Henry LK, Vaughan RA.

Neurochem Int. 2014 Jul;73:16-26. doi: 10.1016/j.neuint.2013.11.003. Epub 2013 Nov 20.


Stereoselective inhibition of serotonin transporters by antimalarial compounds.

Beckman ML, Pramod AB, Perley D, Henry LK.

Neurochem Int. 2014 Jul;73:98-106. doi: 10.1016/j.neuint.2013.10.009. Epub 2013 Oct 23.


SLC6 transporters: structure, function, regulation, disease association and therapeutics.

Pramod AB, Foster J, Carvelli L, Henry LK.

Mol Aspects Med. 2013 Apr-Jun;34(2-3):197-219. doi: 10.1016/j.mam.2012.07.002. Review.


A conserved asparagine residue in transmembrane segment 1 (TM1) of serotonin transporter dictates chloride-coupled neurotransmitter transport.

Henry LK, Iwamoto H, Field JR, Kaufmann K, Dawson ES, Jacobs MT, Adams C, Felts B, Zdravkovic I, Armstrong V, Combs S, Solis E, Rudnick G, Noskov SY, DeFelice LJ, Meiler J, Blakely RD.

J Biol Chem. 2011 Sep 2;286(35):30823-36. doi: 10.1074/jbc.M111.250308. Epub 2011 Jul 5.


Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter.

Thompson BJ, Jessen T, Henry LK, Field JR, Gamble KL, Gresch PJ, Carneiro AM, Horton RE, Chisnell PJ, Belova Y, McMahon DG, Daws LC, Blakely RD.

Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3785-90. doi: 10.1073/pnas.1011920108. Epub 2011 Jan 31. Erratum in: Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6689.


Structural determinants of species-selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studies.

Kaufmann KW, Dawson ES, Henry LK, Field JR, Blakely RD, Meiler J.

Proteins. 2009 Feb 15;74(3):630-42. doi: 10.1002/prot.22178.


Bound to be different: neurotransmitter transporters meet their bacterial cousins.

Henry LK, Meiler J, Blakely RD.

Mol Interv. 2007 Dec;7(6):306-9. doi: 10.1124/mi.7.6.4. Review.


Distinctions between dopamine transporter antagonists could be just around the bend.

Henry LK, Blakely RD.

Mol Pharmacol. 2008 Mar;73(3):616-8. Epub 2007 Dec 21.


Getting the message across: a recent transporter structure shows the way.

Henry LK, DeFelice LJ, Blakely RD.

Neuron. 2006 Mar 16;49(6):791-6. Review.


Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants.

Henry LK, Field JR, Adkins EM, Parnas ML, Vaughan RA, Zou MF, Newman AH, Blakely RD.

J Biol Chem. 2006 Jan 27;281(4):2012-23. Epub 2005 Nov 3.


Serotonin and cocaine-sensitive inactivation of human serotonin transporters by methanethiosulfonates targeted to transmembrane domain I.

Henry LK, Adkins EM, Han Q, Blakely RD.

J Biol Chem. 2003 Sep 26;278(39):37052-63. Epub 2003 Jul 17.


Effects of ozone and oxygen on the degradation of carotenoids in an aqueous model system.

Henry LK, Puspitasari-Nienaber NL, Jarén-Galán M, van Breemen RB, Catignani GL, Schwartz SJ.

J Agric Food Chem. 2000 Oct;48(10):5008-13.


Position 13 analogs of the tridecapeptide mating pheromone from Saccharomyces cerevisiae: design of an iodinatable ligand for receptor binding.

Liu S, Henry LK, Lee BK, Wang SH, Arshava B, Becker JM, Naider F.

J Pept Res. 2000 Jul;56(1):24-34.


Altered expression of selectable marker URA3 in gene-disrupted Candida albicans strains complicates interpretation of virulence studies.

Lay J, Henry LK, Clifford J, Koltin Y, Bulawa CE, Becker JM.

Infect Immun. 1998 Nov;66(11):5301-6.


Attenuated virulence of chitin-deficient mutants of Candida albicans.

Bulawa CE, Miller DW, Henry LK, Becker JM.

Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10570-4.


Reduced virulence of Candida albicans mutants affected in multidrug resistance.

Becker JM, Henry LK, Jiang W, Koltin Y.

Infect Immun. 1995 Nov;63(11):4515-8.


Biological and phytochemical evaluation of plants. X. Test results from a third two-hundred accessions.

Fong HH, Farnsworth NR, Henry LK, Svoboda GH, Yates MJ.

Lloydia. 1972 Mar;35(1):35-48. No abstract available.


Supplemental Content

Loading ...
Support Center